Article
Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Apr 2005
Yonemori Kan, Ueno Hideki, Okusaka Takuji, Yamamoto Noboru, Ikeda Masafumi, Saijo Nagahiro, Yoshida Teruhiko, Ishii Hiroshi, Furuse Junji, Sugiyama Emiko, Kim Su-Ryang, Kikura-Hanajiri Ruri, Hasegawa Ryuichi, Saito Yoshiro, Ozawa Shogo, Kaniwa Nahoko, Sawada Jun-Ichi
Abstract excerpt
PURPOSE: We investigated single-nucleotide polymorphisms of the cytidine deaminase gene (CDA), which encodes an enzyme that metabolizes gemcitabine, to clarify the relationship between the single-nucleotide polymorphism 208G>A and the pharmacokinetics and toxicity of gemcitabine in cancer patients treated with gemcitabine plus cisplatin. EXPERIMENTAL DESIGN: Six Japanese cancer patients treated with gemcitabine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
